Denali Therapeutics Stock Forecast - Rate Of Daily Change

DNLI Stock  USD 27.59  0.17  0.62%   
Denali Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Denali Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
As of now, Denali Therapeutics' Receivables Turnover is increasing as compared to previous years. The Denali Therapeutics' current Asset Turnover is estimated to increase to 0.30, while Inventory Turnover is projected to decrease to (1.33). . The current Common Stock Shares Outstanding is estimated to decrease to about 86.7 M. The Denali Therapeutics' current Net Loss is estimated to increase to about (278.7 M).
Denali Therapeutics has current Rate Of Daily Change of 1.01. Most investors in Denali Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Denali Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Denali Therapeutics' price structures and extracts relationships that further increase the accuracy of the generated results. Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Denali Therapeutics.
Check Denali Therapeutics VolatilityBacktest Denali TherapeuticsInformation Ratio  

Denali Therapeutics Trading Date Momentum

On October 20 2024 Denali Therapeutics was traded for  27.59  at the closing time. The top price for the day was 28.00  and the lowest listed price was  27.43 . There was no trading activity during the period 0.0. Lack of trading volume on October 20, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.29% .
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare Denali Therapeutics to competition

Other Forecasting Options for Denali Therapeutics

For every potential investor in Denali, whether a beginner or expert, Denali Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Denali Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Denali. Basic forecasting techniques help filter out the noise by identifying Denali Therapeutics' price trends.

View Denali Therapeutics Related Equities

 Risk & Return  Correlation

Denali Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Denali Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Denali Therapeutics' current price.

Denali Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Denali Therapeutics shares will generate the highest return on investment. By undertsting and applying Denali Therapeutics stock market strength indicators, traders can identify Denali Therapeutics entry and exit signals to maximize returns.

Denali Therapeutics Risk Indicators

The analysis of Denali Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Denali Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting denali stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Historical Fundamental Analysis of Denali Therapeutics to cross-verify your projections.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.86)
Revenue Per Share
0.009
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.22)
Return On Equity
(0.33)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.